Retention of a functional corpus luteum and peripheral concentrations of 13,14-dihydro-15-keto-prostaglandin F-2 alpha following metestrus administration of Syncro-Mate-B
Jh. Hampton et al., Retention of a functional corpus luteum and peripheral concentrations of 13,14-dihydro-15-keto-prostaglandin F-2 alpha following metestrus administration of Syncro-Mate-B, J ANIM SCI, 77(4), 1999, pp. 948-953
This study was conducted to examine the effects of metestrus administration
of Syncro-Mate-B (SMB) on PGF(2 alpha) secretion and corpus luteum (CL) de
velopment. In a study replicated over 2 yr, cows were observed for spontane
ous estrus in yr 1, and cows received an injection of 25 mg of PGF(2 alpha)
and were observed for subsequent estrus in yr 2. At standing estrus (estru
s = d 1), cows were randomly allotted to receive either the standard SMB re
gimen (n = 40) on d 3 of the estrous cycle or no treatment (n = 8). Fifty p
ercent (n = 20) of SMB-treated cows were administered PGF(2 alpha) on d 10
of the estrous cycle 48 h prior to implant removal. Twice-daily blood sampl
es were collected in the morning (ARI) and evening (PM) from d 2 AM through
d 14 AM: of the treated estrous cycle and subsequently analyzed for proges
terone (P-4) and PGF(2 alpha) metabolite (PCFM). Prior to statistical analy
sis, SMB- and SMB/PGF(2 alpha)-treated cows were sorted according to Pq con
centration, at d 10 of the treated estrous cycle to either a CL functional
group (P-4 greater than or equal to 1 ng/mL; n = 20) or a CL nonfunctional
group (P-4 < 1 ng/mL; n = 17). Following d 10 AM administration of PGF(2 al
pha), functional and nonfunctional groups were further subdivided based on
treatment. The groups were as follows: untreated control cows (n = 8); SMB-
treated cows retaining a functional CL (SMB-F; n = 8); SMB-treated cows wit
h a nonfunctional CL(-SMB-N; n = 11); SMB/PGF(2 alpha)-treated cows retaini
ng a functional CL (SMB/PG-F; n = 12); and SNIB/PGF(2 alpha)-treated cows w
ith a nonfunctional CL (SMB/PG-N; n = 6). Of all SMB-treated cows, 54% reta
ined a functional CL through d 10 AM of the treated estrous cycle. Mean ser
um P-4 concentrations increased for cows in all groups until d 7, after whi
ch P-4 concentrations increased for cows in SMB/PG-F, SMB-F, and control gr
oups and decreased for cows in SNIB/PG-N and SMB-N groups. Following PGF(2
alpha) administration on d 10, mean serum P-4 concentrations remained < 1 n
g/mL for cows in SMB/PG-N and SMB-N groups, decreased to < 1 ng/mL for cows
in the SMB/ PG-F group, and remained > 1 ng/ml for cows in SMB-F and contr
ol groups. Mean serum PGFM concentrations tended (P = .06) to increase in c
ows with nonfunctional CL compared with control cows on d 8 ANI and were gr
eater (P < .05) in cows with functional CL on d 8 PM through d 9 PM. These
results indicate that retention of a functional rather than a nonfunctional
CL following metestrus adminis- tration of SMB is dependent on a premature
release of uterine PGF(2 alpha).